JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
173 hedge funds and large institutions have $2.28B invested in Juno Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
+16
Holders Change %
+10.19%
% of All Funds
4.32%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
36
Increased
52
Reduced
50
Closed
20
Calls
$31.1M
Puts
$45.3M
Net Calls
-$14.2M
Net Calls Change
-$9.58M
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
$66.3M |
| 2 |
O
OrbiMed
New York
|
$27.4M |
| 3 |
Jennison Associates
New York
|
$22.7M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$19.8M |
| 5 |
Morgan Stanley
New York
|
$43.3M |
